The future of clinical trials of gut microbiome therapeutics in cirrhosis.

ABSTRACT: The last two decades have witnessed an explosion of microbiome research, including in hepatology, with studies demonstrating altered microbial composition in liver disease. More recently, efforts have been made to understand the association of microbiome features with clinical outcomes and to develop therapeutics targeting the microbiome. While microbiome therapeutics hold much promise, their unique features pose certain challenges for the design and conduct of clinical trials. Herein, we will briefly review indications for microbiome therapeutics in cirrhosis, currently available microbiome therapeutics, and the biological pathways targeted by these therapies. We will then focus on the best practices and important considerations for clinical trials of gut microbiome therapeutics in cirrho

SUBMITTER: Bloom PP 

PROVIDER: S-EPMC11663965 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature